Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Immunol. 2016 May 27;197(1):368–376. doi: 10.4049/jimmunol.1502628

Figure 5.

Figure 5

(A) Frequency of CCR7hi CD4 T cells from FGT compared to matched blood measured according to self-reported menstrual cycle phase. (B) Average blood plasma levels of Progesterone and Estradiol shown at indicated timepoints throughout menstrual cycle. Day of cycle represent range estimated from self-reported start of menses. (C) Frequency of CCR7hi CD4 T cells from the FGT measured at indicated timepoints progesterone and estradiol were measured. (D) Progesterone levels compared to FGT CCR7hi CD4 T cell frequency. Statistics calculated by Spearman correlation (Pearson correlation also performed and show significance, r=0.4079 and p=0.0032). (E) Estradiol levels compared to FGT CCR7hi CD4 T cell frequency. Statistics calculated by Spearman correlation (Pearson correlation also performed and show no significance r=0.3006 and p=0.2111).

HHS Vulnerability Disclosure